NYSE · Unclassified100% Authentic Upstream Feed (MR-007)

Resmed Inc (RMD)

Real-time institutional stock price, dual quantitative model evaluation (4-Factor Quant Rank + 6-Factor Fundamental Composite), valuation multiples, and forensic accounting audit.

Live Authentic Market Price
$235.24
+$1.11 (+0.47%)
Vol: 264,800
Market Capitalization$33.09B
P/E Multiple (TTM)21.43
52-Week Range$180.26 – $277.67
Beta / Volatility0.77
Model A · Equal-Weight 25%

4-Factor Quant Rank

#617
Percentile Score:63.3 / 100
Valuation Percentile:67.4
Growth Percentile:61.2
Business Quality Percentile:90.9
Momentum Percentile:33.7
Cross-sectional universe comparison across 2,714 U.S. equities (Official v2.1).
Model B · Fundamental Pillars

6-Factor Fundamental Rating

A
Fundamental Score:Partial
84/100
Valuation:A+
Growth:A
Profitability:A+
Financial Health:—
EPS Revisions:—
Dividend Quality:A-
Absolute balance sheet health and SEC Edgar filing verification.

Source-Backed Financial Highlights

SEC EDGAR & Market Data Lineage
Revenue (TTM)$5.65B
Diluted EPS$10.98
Forward P/E17.79
Price to Sales—
Operating Margin3402.0%
Net Margin2779.0%